Concordare Named Finalist in 2026 Fierce AI Innovation Awards

Concordare has been named a finalist in Fierce's AI Innovation Awards, which recognize companies using AI to deliver measurable impact across life sciences and healthcare.

Our mission is to rethink the clinical trial protocol as a single, human-verified digital core, from which any stakeholder can generate documents and system configurations. This recognition reflects the real-world impact of faster, higher-quality clinical trials.

Related posts

• 
  Company News

  Concordare Submits Public Comment to FDA on the Expedited IND Pilot Program

  July 2026 · 2 min read
• 
  Product Update

  Audit of Concordare's Digital Protocol AI Conversion Engine Achieves 99.6% Accuracy

  July 2026 · 3 min read
• 
  Product Update

  Introducing the Clinical Trial Protocol Model (CTPM)

  May 6, 2026 · 5 min read